ADAM MIKIEWICZ: Open Payments
NPI 1184136590 · ROCKY HILL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,746 in 52 payments from 11 companies in 2025. Trend: 2023 $543 · 2024 $640 · 2025 $1,746
Food & beverage: $1,746
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $472 |
| Collegium Pharmaceutical, Inc. | 11 | $250 |
| E.R. Squibb & Sons, L.L.C. | 7 | $212 |
| Neurocrine BioSciences, Inc. | 4 | $179 |
| ABBVIE INC. | 7 | $176 |
| Axsome Therapeutics, Inc. | 3 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| TMS NeuroHealth Centers Inc. | 2 | $43 |
| Corium, LLC | 2 | $41 |
Products named: Jornay PM, ARISTADA, COBENFY, INGREZZA, VRAYLAR, Auvelity, VIVITROL, LYBALVI.
Industry payments across CT — which companies pay providers there.
